Our website uses its own and third parties cookies for a high level of user-friendliness. If you continue to browse and  use this website we will assume that you agree with the policies.


ATRYS HEALTH will be listed on regular mode in the MAB and will be part of the IBEX MAB® Index 15

March 20, 2018

ATRYS HEALTH, a company dedicated to the provision of diagnostic services and medical treatments of excellence, has received the notification of the operative instruction according to which it will pass, from March 21, to the modality of general contracting within the MAB, that is, with an open session period between the opening and closing auctions.

ATRYS HEALTH finalized last February a capital increase of € 13.15m, made in three tranches, representing the second largest capital increase carried out in the MAB environment in the last three years.

The last tranche of this capital increase, of € 4M, was executed on February 15 and addressed to retail investors, and obtained one of the largest over subscriptions in a company listed on the MAB. This increase has meant an increase in the shareholder base of the company, which has allowed ATRYS to go on a continuous quotation in the Alternative Stock Market.

Also, in this line, it should also be noted that at its meeting on March 12, the Technical Advisory Committee of BME approved that the company's shares will begin trading on the IBEX MAB® 15 index as of Monday, March 19 March.